Prenatal maternal COVID-19 vaccination and pregnancy outcomes

BACKGROUND: Prenatal maternal physiological changes may cause severe COVID-19 among pregnant women. The Pfizer-BioNTech COVID-19 vaccine (BNT162b2 mRNA) has been shown to be highly effective and it is recommended for individuals aged ≥16 years, including pregnant women, although the vaccine has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Wainstock, Tamar, Yoles, Israel, Sergienko, Ruslan, Sheiner, Eyal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421099/
https://www.ncbi.nlm.nih.gov/pubmed/34531079
http://dx.doi.org/10.1016/j.vaccine.2021.09.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421099/
https://www.ncbi.nlm.nih.gov/pubmed/34531079
http://dx.doi.org/10.1016/j.vaccine.2021.09.012

Ejemplares similares